Literature DB >> 9623970

Exposing gliadin as a tasty food for lymphocytes.

D Schuppan, W Dieterich, E O Riecken.   

Abstract

Mesh:

Substances:

Year:  1998        PMID: 9623970     DOI: 10.1038/nm0698-666

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  8 in total

1.  Transglutaminase and coeliac disease: endomysial reactivity and small bowel expression.

Authors:  G Brusco; P Muzi; R Ciccocioppo; F Biagi; M G Cifone; G R Corazza
Journal:  Clin Exp Immunol       Date:  1999-12       Impact factor: 4.330

Review 2.  Recent advances in the understanding of celiac disease: therapeutic implications for the management of pediatric patients.

Authors:  John H Kwon; Richard J Farrell
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022

3.  Parallel expression of macrophage metalloelastase (MMP-12) in duodenal and skin lesions of patients with dermatitis herpetiformis.

Authors:  M T Salmela; S L Pender; T Reunala; T MacDonald; U Saarialho-Kere
Journal:  Gut       Date:  2001-04       Impact factor: 23.059

4.  Immune reaction against the cytoskeleton in coeliac disease.

Authors:  M G Clemente; M P Musu; F Frau; G Brusco; G Sole; G R Corazza; S De Virgiliis
Journal:  Gut       Date:  2000-10       Impact factor: 23.059

5.  Role of anti-transglutaminase (anti-tTG), anti-gliadin, and anti-endomysium serum antibodies in diagnosing celiac disease: a comparison of four different commercial kits for anti-tTG determination.

Authors:  D Basso; N Gallo; G Guariso; M Pittoni; M G Piva; M Plebani
Journal:  J Clin Lab Anal       Date:  2001       Impact factor: 2.352

6.  Features of ZED1227: The First-In-Class Tissue Transglutaminase Inhibitor Undergoing Clinical Evaluation for the Treatment of Celiac Disease.

Authors:  Christian Büchold; Martin Hils; Uwe Gerlach; Johannes Weber; Christiane Pelzer; Andreas Heil; Daniel Aeschlimann; Ralf Pasternack
Journal:  Cells       Date:  2022-05-17       Impact factor: 7.666

7.  Celiac anti-type 2 transglutaminase antibodies induce phosphoproteome modification in intestinal epithelial Caco-2 cells.

Authors:  Gaetana Paolella; Ivana Caputo; Anna Marabotti; Marilena Lepretti; Anna Maria Salzano; Andrea Scaloni; Monica Vitale; Nicola Zambrano; Daniele Sblattero; Carla Esposito
Journal:  PLoS One       Date:  2013-12-31       Impact factor: 3.240

8.  Gliadin peptides induce tissue transglutaminase activation and ER-stress through Ca2+ mobilization in Caco-2 cells.

Authors:  Ivana Caputo; Agnese Secondo; Marilena Lepretti; Gaetana Paolella; Salvatore Auricchio; Maria Vittoria Barone; Carla Esposito
Journal:  PLoS One       Date:  2012-09-25       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.